| Item | Value |
|---|---|
| DrugBank ID | DB04844 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 25 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Huntington disease | TxGNN Knowledge Graph |
| 2 | Huntington disease-like syndrome due to C9ORF72 expansions | TxGNN Knowledge Graph |
| 3 | Huntington disease-like | TxGNN Knowledge Graph |
| 4 | McLeod neuroacanthocytosis syndrome | TxGNN Knowledge Graph |
| 5 | juvenile Huntington disease | TxGNN Knowledge Graph |
| 6 | Huntington disease | TxGNN Knowledge Graph |
| 7 | Huntington disease-like syndrome due to C9ORF72 expansions | TxGNN Knowledge Graph |
| 8 | Huntington disease-like | TxGNN Knowledge Graph |
| 9 | McLeod neuroacanthocytosis syndrome | TxGNN Knowledge Graph |
| 10 | juvenile Huntington disease | TxGNN Knowledge Graph |
| 11 | Huntington disease | TxGNN Knowledge Graph |
| 12 | Huntington disease-like syndrome due to C9ORF72 expansions | TxGNN Knowledge Graph |
| 13 | Huntington disease-like | TxGNN Knowledge Graph |
| 14 | McLeod neuroacanthocytosis syndrome | TxGNN Knowledge Graph |
| 15 | juvenile Huntington disease | TxGNN Knowledge Graph |
| 16 | Huntington disease | TxGNN Knowledge Graph |
| 17 | Huntington disease-like syndrome due to C9ORF72 expansions | TxGNN Knowledge Graph |
| 18 | Huntington disease-like | TxGNN Knowledge Graph |
| 19 | McLeod neuroacanthocytosis syndrome | TxGNN Knowledge Graph |
| 20 | juvenile Huntington disease | TxGNN Knowledge Graph |
| 21 | Huntington disease | TxGNN Knowledge Graph |
| 22 | Huntington disease-like syndrome due to C9ORF72 expansions | TxGNN Knowledge Graph |
| 23 | Huntington disease-like | TxGNN Knowledge Graph |
| 24 | McLeod neuroacanthocytosis syndrome | TxGNN Knowledge Graph |
| 25 | juvenile Huntington disease | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.